MoonLake Immunotherapeutics
MLTX
#3397
Rank
NZ$5.81 B
Marketcap
$92.25
Share price
0.56%
Change (1 day)
-0.93%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2023 (TTM): -$1.93

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -$2.07. In 2022 the company made an earnings per share (EPS) of -$2.62.

EPS history for MoonLake Immunotherapeutics from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.93-26.23%
2022-$2.62